The evidence is mixed2 supporting, 3 against, 0 worth knowing
Supporting
trading 8% above its 200-day average
net margin has widened from -33.1% to -22.4% across four quarters
Against
down 16% over twelve months
1 of the scans it matches has historically underperformed the market
revenue fell 8% year on year in the quarter ending 30 June 2026
Worth knowing
nothing the data supports either way
What would change this read: a close below 664, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working3
Astec LifeSciences' net profit as a share of revenue moved from -36.3% to -22.4% against the same quarter last year.
-36.3%-22.4%
Profit rose year on year in all 4 of the last 4 quarters.
4
Trading 7.8% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+7.8%
Needs watching3
Revenue -8.3% year on year, Rs 91 cr to Rs 84 cr.
-8.3%Rs 91 crRs 84 cr
Down 15.8% over the past year.
-15.8%
Only Rs 2.2 crore changes hands on a median day. A large order moves this price by itself.
Rs 2.2 cr
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 2 of these 3 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
3 of 47 matched on 10 Sep
ASTEC matches 3 of the 47 scans today, across 2 different kinds of evidence.
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
nothing clear in the filed numbers
Going against it
revenue fell 8% against the same quarter a year earlier
profit dropped 43% year on year
net margin narrowed from -4.9% to -22.4%
the company has not been profitable over the last four filed quarters
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
84
-19
-19
—
-22.4%
Q4 FY26
31 Mar · consolidated
159
-8
-8
—
-4.9%
Q3 FY26
31 Dec · consolidated
125
-16
-16
—
-12.6%
Q2 FY26
30 Sep · consolidated
74
-24
-24
—
-33.1%
Q1 FY26
30 Jun · consolidated
91
-33
-33
—
-36.3%
Q4 FY25
31 Mar · consolidated
120
-16
-16
—
-13.5%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+12.6%
Versus 200-day average+7.8%
Below 52-week high-22.1%
Above 52-week low+37.2%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)66.9
Higher closes in last 52 of 5
Six-month return+20.24%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)5.38%
Volume versus 20-day1.3x
Median daily turnoverRs 2.2 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.
Session
Scans
Which
9 Sep
2
Trading far more than usual, Gapped up and held it
8 Sep
5
Trading far more than usual, Bullish engulfing, Closed at the very top of its range, Closed at the day's high, MACD just turned positive